glp-1 treatment gonzales Therapy Weight Loss Medication GLP-1 Agonists: A Comprehensive Overview

As semaglutide users lose weight, their bodies require less cholesterol production, naturally lowering blood levels

22 Currently, there is no licenced therapy for IIH

conducted target trial emulations comparing dual GLP-1/GIP agonists to GLP-1 monotherapy in patients with type 2 diabetes, finding that dual agonists were linked to numerically lower risks of MALOs, although confidence intervals overlapped, suggesting that extended observation period and larger patient cohorts may be needed to definitively establish comparative effectiveness [61]

The company is also not currently profitable, although as of the latest quarter, it is sitting on a healthy $706 million in cash reserves